Biocon Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 706.50 | 1,234.50 | 598.90 |
| Operating Expense | 581.80 | 531.50 | 487.80 |
| Net Profit | 21.20 | 584 | 3.20 |
| Net Profit Margin | 3.00 | 47.31 | 0.53 |
| Earning Per Share | 0.18 | 4.88 | 0.03 |
| EBIDTA | 137.40 | 691.50 | 106.60 |
| Effective Tax Rate | 21.25 | 1.19 | 11.88 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 706.50 |
| Operating Expense | 581.80 |
| Net Profit | 21.20 |
| Net Profit Margin | 3.00 |
| Earning Per Share | 0.18 |
| EBIDTA | 137.40 |
| Effective Tax Rate | 21.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2,127.30 | 1,992.90 | 1,738.20 |
| Operating Expenses Annual | 1,864.60 | 1,969.40 | 1,677.10 |
| Operating Profit Annual | 470.20 | 3,157.70 | 248.30 |
| Interest Annual | 198.80 | 69.60 | 0.40 |
| Depreciation | 114.10 | 108.30 | 100.70 |
| Net Profit Annual | 119.30 | 2,848.40 | 86.10 |
| Tax Annual | 31 | 122.80 | 53.60 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2,127.30 |
| Operating Expenses Annual | 1,864.60 |
| Operating Profit Annual | 470.20 |
| Interest Annual | 198.80 |
| Depreciation | 114.10 |
| Net Profit Annual | 119.30 |
| Tax Annual | 31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 196.60 | 111 | 253.50 |
| Cash Flow from Operations | -123.20 | 219.30 | 47.60 |
| Cash Flow from Investing | -294.70 | -1,173.10 | -302.10 |
| Cash Flow from Financing | 343.60 | 1,039.40 | 112 |
| Cash Flow at the End | 122.30 | 196.60 | 111 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 196.60 |
| Cash Flow from Operations | -123.20 |
| Cash Flow from Investing | -294.70 |
| Cash Flow from Financing | 343.60 |
| Cash Flow at the End | 122.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 21.31 | 13.60 | 14.28 |
| PBIT Margin (%) | 15.62 | 7.74 | 8.06 |
| PBT Margin (%) | 15.54 | 7.63 | -12.09 |
| Net PROFIT Margin (%) | 5.61 | 142.93 | 4.95 |
| Return On Networth / Equity (%) | 0.97 | -0.14 | 1.08 |
| Return On Networth /Employed (%) | 2.61 | 1.50 | 1.72 |
| Return On Assets (%) | 0.95 | 27.16 | 1.04 |
| Total Debt / Equity (X) | 0.15 | 0.07 | 0.01 |
| Asset Turnover Ratio (%) | 0.17 | 0.19 | 0.21 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 21.31 |
| PBIT Margin (%) | 15.62 |
| PBT Margin (%) | 15.54 |
| Net PROFIT Margin (%) | 5.61 |
| Return On Networth / Equity (%) | 0.97 |
| Return On Networth /Employed (%) | 2.61 |
| Return On Assets (%) | 0.95 |
| Total Debt / Equity (X) | 0.15 |
| Asset Turnover Ratio (%) | 0.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 915 | 914 | 819.30 |
| Total Current Assets Annual | 2,760 | 2,566 | 2,402.20 |
| Non Current Assets Annual | 11,008.20 | 10,463.90 | 6,466.80 |
| Total Shareholders Funds Annual | 10,912.30 | 10,916 | 8,092.90 |
| Total Assets Annual | 13,768.20 | 13,029.90 | 8,869 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 915 |
| Total Current Assets Annual | 2,760 |
| Non Current Assets Annual | 11,008.20 |
| Total Shareholders Funds Annual | 10,912.30 |
| Total Assets Annual | 13,768.20 |
EPS (INR)
Expected
2.87
Reported
2.88
Surprise
0.35%
Dec 2024
EPS beaten by 0.35%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
